Advertisement
Advertisement
Advertisement
Advertisement
EU Makes U-turn After Facing Global Backlash Over Vaccine Export

EU Makes U-turn After Facing Global Backlash Over Vaccine Export

EU Makes U-turn After Facing Global Backlash Over Vaccine Export
Advertisement

The European Union (EU) has decided to suspend its exports due to a shortage of the vaccine. However, the decision was withdrawn after strong international criticism.

The European Union (EU) has said in response to a lack of availability of the AstraZeneca vaccine in its countries that exports of the vaccine to Northern Ireland will be restricted so that the first vaccine can be given to its own people. The EU’s stance has caused a stir in Britain and Ireland, with governments calling such a move a violation of the recently concluded Bridgett Accords.

The World Health Organization (WHO) has also openly criticized the European Union, saying “nationalist” tendencies over vaccine availability are “disturbing”. According to the WHO, the Corona epidemic is a global challenge and countries need to think beyond their borders to meet it.

Such a ban by the European Union could affect the availability of the vaccine in hundreds of countries, including the United Kingdom, the United States, Canada and Australia.

According to EU officials, the purpose of restricting vaccine exports was to protect the health of citizens of member countries, which is its top priority.

Advertisement

However, in a statement, the European bloc’s health commissioner, Stella Kyriakides, said that they are not trying to protect ourselves from any particular country, nor are they competing with any other country.

The European Union (EU) has said in a statement that the proposed reduction in vaccine exports was “temporary” and was not intended to curb exports.

Under EU rules and regulations, the authorities have the power to suspend vaccine exports from a pharmaceutical company on the grounds that it has not fulfilled its agreements with member states.

AstraZeneca is a British and Swedish company that developed the ‘Oxford’ vaccine to prevent corona.

The European Union (EU) has been at loggerheads with the company over not providing as many vaccines as it had promised.

 

Advertisement

Also Read

WHO To Provide 40 Million Doses Of COVID Vaccine To Poor Countries
WHO To Provide 40 Million Doses Of COVID Vaccine To Poor Countries

Pfizer and Biotech will supply 40 million doses of the coronavirus vaccine...

Advertisement
Advertisement
Read More News On

Catch all the International News, Breaking News Event and Latest News Updates on The BOL News


Download The BOL News App to get the Daily News Update & Follow us on Google News.


End of Article

Next Story